Skip to content

Carbon Dioxide-laser Versus Harmonic Scalpel in the Treatment of Pelvic Pain Due to Endometriosis

Carbon Dioxide-laser Versus Harmonic Scalpel in the Treatment of Pelvic Pain Due to Endometriosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02282943
Enrollment
112
Registered
2014-11-05
Start date
2002-10-31
Completion date
2016-06-30
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

endometriosis, CO2 laser vapourisation, Harmonic scalpel, AFS stage I-III

Brief summary

The purpose of this study is to compare laser CO2 ablation/excision of Endometriosis (AFS stages 1-3) with excision of endometriosis using the Ethicon Harmonic ACE device. Pain scores at 6 months was the primary outcome, but secondary outcomes assessed pain scores at 1, 3 and 5 years as well as psychological state and quality of life.

Interventions

DEVICELaser

Vapourisation/excision of endometriosis AFS stages I-III using CO2 laser

Excision of endometriosis using Harmonic scalpel

Sponsors

Mr Andrew Kent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Endometriosis grade I-III by revised American Fertility Society Scoring * Patients in whom laser treatment to the endometriosis is considered the treatment of choice. * Patients having consented to participated in the trial * Patient is 18 years old or greater * Patients who have no contraindications to either of the treatment modalities proposed

Exclusion criteria

* Patients who do not wish to participate/have not signed the informed consent form * Pregnancy of breast feeding * Patients who are unable or unwilling to discontinue hormonal treatment for 6 months * Patients who have received additional treatment for their endometriosis within 6 months of surgery * Patients with documented painful conditions of the gastrointestinal or urinary system

Design outcomes

Primary

MeasureTime frame
Visual analogue pain score (VAS) change at 6 months compared to preoperative baseline6 months

Secondary

MeasureTime frameDescription
Quality of life survey (Endometriosis Health Profile Questionnaire)0, 3, 6 months and 1,3,5 years
Psychological state0, 3 ,6 months and 1,3,5 yearsHospital Anxiety & Depression Scale
Visual analogue pain score (VAS) change from baseline1,3 and 5 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026